Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Increased risk of Pandemic
View:
Post by enriquesuave on Oct 14, 2024 11:40am

Increased risk of Pandemic

Comment by TommyNickels on Oct 15, 2024 6:34am
My bet is that Roger will support the stock with a series of pre-clinical successes furthering the MASSIVE potential of Rutherrin. And yes, Bird Flu could be one of these successes. This is.what makes Theralase so valuable. First we need to see approval of the pre-BTD application. And either a timeline for BTD application or news that it was filed.  News is possible this week but more ...more  
Comment by TommyNickels on Oct 15, 2024 6:39am
Of course always possible the FDA asks for more data, more clarification, more certainty. Says to try again in 6 months. If this is the case, don't expect a PR with this news ! Instead, will be another 500,000$ raise to get us further along.
Comment by Longholder99 on Oct 15, 2024 7:58am
Was just a matter of time before the soft bash started..  ignored
Comment by TommyNickels on Oct 15, 2024 8:26am
So only 100% uber-positive is allowed ? To anyone who thinks it's 100% guaranteed that FDA approval is coming, you aren't grounded in reality. Odds stacked in your favour? Yup. Impossible for the FDA to ask for more data
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250